|
Real-time Estimate
Cboe BZX
20:41:47 21/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 19.26 USD | +3.38% |
|
+12.16% | +12.26% |
| 08-13 | Omeros Corporation Announces Appointment of Joseph Schocken as Director and Audit Committee Member, Effective August 12, 2026 | CI |
| 08-13 | Omeros Swings to Q2 Adjusted Earnings; Shares up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OMEROS CORPORATION | Bio Therapeutic Drugs | +3.65% | +12.16% | +12.26% | +330.36% | +28.96% | 1.35B |  | | |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
